Jiajun Y. Fan
170 Xinsong Road
Minhang, 201199, China
Minhang, 201199, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Regulation of natural killer cell infiltration and tumor progression by CMTM6 in gastric cancer.
Journal: BMC cancer
Published: January 13, 2026
Oncogenic KRAS represses the dependence receptor UNC5C via ERK2-FOS signaling in non-small cell lung cancer.
Journal: The Journal of biological chemistry
Published: November 07, 2025
Targeting angiopoietin-like protein 3 and interleukin-1β alleviated liver and kidney injury through attenuation of lipotoxicity and regulation of glycolipid metabolism in db/db mice.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: October 23, 2025
Hydrodynamic controls on sulfate cycling in karst mining area groundwater: A multi-isotope and microbiology constraint.
Journal: Journal of environmental management
Published: September 01, 2025
Improved biodistribution and antitumor effects of a Nectin4 and Trop2 bispecific fatty acid-modified nanobody conjugate.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 03, 2025
DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ductal Adenocarcinoma.
Journal: International journal of molecular sciences
Published: June 01, 2025
Anti-angiogenesis enhances the tumor immunotherapeutical effect of recombinant CD80 fusion protein.
Journal: International journal of biological macromolecules
Published: February 21, 2025
Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy.
Journal: International journal of biological macromolecules
Published: October 26, 2024
Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: August 14, 2024
Simultaneously blocking ANGPTL3 and CD47 prevents the progression of atherosclerosis through regulating lipid metabolism, macrophagic efferocytosis and lipid peroxidation.
Journal: Pharmacological research
Published: August 04, 2024
Rubicon siRNA-encapsulated liver-targeting nanoliposome is a promising therapeutic for non-alcoholic fatty liver disease.
Journal: International journal of pharmaceutics
Published: July 09, 2024
Simultaneously blocking ANGPTL3 and IL-1β for the treatment of atherosclerosis through lipid-lowering and anti-inflammation.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: July 04, 2024
Last Updated: 09/26/2026